10.5281/zenodo.1154257
https://zenodo.org/records/1154257
oai:zenodo.org:1154257
Genna M. Luciani
Genna M. Luciani
0000-0001-8107-2708
Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network
Dalia Barsyte-Lovejoy
Dalia Barsyte-Lovejoy
Structural Genomics Consortium, University of Toronto
Mark Minden
Mark Minden
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Cheryl Arrowsmith
Cheryl Arrowsmith
Structural Genomics Consortium, Princess Margaret Cancer Centre, University Health Network, University of Toronto
Generation of fluorescently labelled OP9 stromal cells for growing patient leukemic cells
Zenodo
2018
OP9 stroma
fluorescent stromal cells
co-culture
2018-01-17
10.5281/zenodo.1154256
https://zenodo.org/communities/sgc-opennotebook
https://zenodo.org/communities/openlabnotebooks
Creative Commons Attribution 4.0 International
We added fluorescent labels to OP9 stromal cells to allow us to easily distinguish stromal cells from primary leukemia cells in co-culture growth conditions.
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. This project receives funding from the Leukemia and Lymphoma Society of Canada.